USA Autologous Cell Therapy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Autologous Cell Therapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Autologous Cell Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Autologous Cell Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Takeda Pharmaceutical Co Ltd

    • Bayer AG

    • Vericel Corp

    • Daiichi Sankyo Co Ltd

    • Holostem Terapie Avanzate Srl

    • Brainstorm Cell Therapeutics Inc

    • Sumitomo Chemical Co Ltd

    • FUJIFILM Holdings Corp

    • Teva Pharmaceutical Industries Ltd

    • Osiris Therapeutics Inc

    By Type:

    • Bone Marrow

    • Epidermis

    By End-User:

    • Cancer

    • Neurodegenerative Diseases

    • Wound Healing

    • Orthopedic

    • Cardiovascular diseases

    • Autoimmune Diseases

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Autologous Cell Therapy Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Autologous Cell Therapy Market Size and Growth Rate of Bone Marrow from 2016 to 2027

      • 1.3.2 USA Autologous Cell Therapy Market Size and Growth Rate of Epidermis from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Autologous Cell Therapy Market Size and Growth Rate of Cancer from 2016 to 2027

      • 1.4.2 USA Autologous Cell Therapy Market Size and Growth Rate of Neurodegenerative Diseases from 2016 to 2027

      • 1.4.3 USA Autologous Cell Therapy Market Size and Growth Rate of Wound Healing from 2016 to 2027

      • 1.4.4 USA Autologous Cell Therapy Market Size and Growth Rate of Orthopedic from 2016 to 2027

      • 1.4.5 USA Autologous Cell Therapy Market Size and Growth Rate of Cardiovascular diseases from 2016 to 2027

      • 1.4.6 USA Autologous Cell Therapy Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027

      • 1.4.7 USA Autologous Cell Therapy Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Autologous Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Autologous Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Autologous Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Autologous Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Autologous Cell Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Autologous Cell Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Bone Marrow

      • 3.4.2 Market Size and Growth Rate of Epidermis

    4 Segmentation of Autologous Cell Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Autologous Cell Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Autologous Cell Therapy in Cancer

      • 4.4.2 Market Size and Growth Rate of Autologous Cell Therapy in Neurodegenerative Diseases

      • 4.4.3 Market Size and Growth Rate of Autologous Cell Therapy in Wound Healing

      • 4.4.4 Market Size and Growth Rate of Autologous Cell Therapy in Orthopedic

      • 4.4.5 Market Size and Growth Rate of Autologous Cell Therapy in Cardiovascular diseases

      • 4.4.6 Market Size and Growth Rate of Autologous Cell Therapy in Autoimmune Diseases

      • 4.4.7 Market Size and Growth Rate of Autologous Cell Therapy in Other

    5 Market Analysis by Regions

    • 5.1 USA Autologous Cell Therapy Production Analysis by Regions

    • 5.2 USA Autologous Cell Therapy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Autologous Cell Therapy Landscape Analysis

    • 6.1 West USA Autologous Cell Therapy Landscape Analysis by Major Types

    • 6.2 West USA Autologous Cell Therapy Landscape Analysis by Major End-Users

    7 South USA Autologous Cell Therapy Landscape Analysis

    • 7.1 South USA Autologous Cell Therapy Landscape Analysis by Major Types

    • 7.2 South USA Autologous Cell Therapy Landscape Analysis by Major End-Users

    8 Middle West USA Autologous Cell Therapy Landscape Analysis

    • 8.1 Middle West USA Autologous Cell Therapy Landscape Analysis by Major Types

    • 8.2 Middle West USA Autologous Cell Therapy Landscape Analysis by Major End-Users

    9 Northeast USA Autologous Cell Therapy Landscape Analysis

    • 9.1 Northeast USA Autologous Cell Therapy Landscape Analysis by Major Types

    • 9.2 Northeast USA Autologous Cell Therapy Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Takeda Pharmaceutical Co Ltd

        • 10.1.1 Takeda Pharmaceutical Co Ltd Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Bayer AG

        • 10.2.1 Bayer AG Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Vericel Corp

        • 10.3.1 Vericel Corp Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Daiichi Sankyo Co Ltd

        • 10.4.1 Daiichi Sankyo Co Ltd Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Holostem Terapie Avanzate Srl

        • 10.5.1 Holostem Terapie Avanzate Srl Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Brainstorm Cell Therapeutics Inc

        • 10.6.1 Brainstorm Cell Therapeutics Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Sumitomo Chemical Co Ltd

        • 10.7.1 Sumitomo Chemical Co Ltd Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 FUJIFILM Holdings Corp

        • 10.8.1 FUJIFILM Holdings Corp Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Teva Pharmaceutical Industries Ltd

        • 10.9.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Osiris Therapeutics Inc

        • 10.10.1 Osiris Therapeutics Inc Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Bone Marrow from 2016 to 2027

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Epidermis from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Neurodegenerative Diseases from 2016 to 2027

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Wound Healing from 2016 to 2027

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Orthopedic from 2016 to 2027

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Cardiovascular diseases from 2016 to 2027

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027

    • Figure USA Autologous Cell Therapy Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Autologous Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Autologous Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Autologous Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Autologous Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Autologous Cell Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Autologous Cell Therapy

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Autologous Cell Therapy by Different Types from 2016 to 2027

    • Table Consumption Share of Autologous Cell Therapy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Bone Marrow

    • Figure Market Size and Growth Rate of Epidermis

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Autologous Cell Therapy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Autologous Cell Therapy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Neurodegenerative Diseases

    • Figure Market Size and Growth Rate of Wound Healing

    • Figure Market Size and Growth Rate of Orthopedic

    • Figure Market Size and Growth Rate of Cardiovascular diseases

    • Figure Market Size and Growth Rate of Autoimmune Diseases

    • Figure Market Size and Growth Rate of Other

    • Table USA Autologous Cell Therapy Production by Regions

    • Table USA Autologous Cell Therapy Production Share by Regions

    • Figure USA Autologous Cell Therapy Production Share by Regions in 2016

    • Figure USA Autologous Cell Therapy Production Share by Regions in 2021

    • Figure USA Autologous Cell Therapy Production Share by Regions in 2027

    • Table USA Autologous Cell Therapy Consumption by Regions

    • Table USA Autologous Cell Therapy Consumption Share by Regions

    • Figure USA Autologous Cell Therapy Consumption Share by Regions in 2016

    • Figure USA Autologous Cell Therapy Consumption Share by Regions in 2021

    • Figure USA Autologous Cell Therapy Consumption Share by Regions in 2027

    • Table West USA Autologous Cell Therapy Consumption by Types from 2016 to 2027

    • Table West USA Autologous Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure West USA Autologous Cell Therapy Consumption Share by Types in 2016

    • Figure West USA Autologous Cell Therapy Consumption Share by Types in 2021

    • Figure West USA Autologous Cell Therapy Consumption Share by Types in 2027

    • Table West USA Autologous Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table West USA Autologous Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Autologous Cell Therapy Consumption Share by End-Users in 2016

    • Figure West USA Autologous Cell Therapy Consumption Share by End-Users in 2021

    • Figure West USA Autologous Cell Therapy Consumption Share by End-Users in 2027

    • Table South USA Autologous Cell Therapy Consumption by Types from 2016 to 2027

    • Table South USA Autologous Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure South USA Autologous Cell Therapy Consumption Share by Types in 2016

    • Figure South USA Autologous Cell Therapy Consumption Share by Types in 2021

    • Figure South USA Autologous Cell Therapy Consumption Share by Types in 2027

    • Table South USA Autologous Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table South USA Autologous Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Autologous Cell Therapy Consumption Share by End-Users in 2016

    • Figure South USA Autologous Cell Therapy Consumption Share by End-Users in 2021

    • Figure South USA Autologous Cell Therapy Consumption Share by End-Users in 2027

    • Table Middle West USA Autologous Cell Therapy Consumption by Types from 2016 to 2027

    • Table Middle West USA Autologous Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Autologous Cell Therapy Consumption Share by Types in 2016

    • Figure Middle West USA Autologous Cell Therapy Consumption Share by Types in 2021

    • Figure Middle West USA Autologous Cell Therapy Consumption Share by Types in 2027

    • Table Middle West USA Autologous Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Autologous Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Autologous Cell Therapy Consumption Share by End-Users in 2016

    • Figure Middle West USA Autologous Cell Therapy Consumption Share by End-Users in 2021

    • Figure Middle West USA Autologous Cell Therapy Consumption Share by End-Users in 2027

    • Table Northeast USA Autologous Cell Therapy Consumption by Types from 2016 to 2027

    • Table Northeast USA Autologous Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Autologous Cell Therapy Consumption Share by Types in 2016

    • Figure Northeast USA Autologous Cell Therapy Consumption Share by Types in 2021

    • Figure Northeast USA Autologous Cell Therapy Consumption Share by Types in 2027

    • Table Northeast USA Autologous Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Autologous Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Autologous Cell Therapy Consumption Share by End-Users in 2016

    • Figure Northeast USA Autologous Cell Therapy Consumption Share by End-Users in 2021

    • Figure Northeast USA Autologous Cell Therapy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Takeda Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Takeda Pharmaceutical Co Ltd

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of Vericel Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vericel Corp

    • Figure Sales and Growth Rate Analysis of Vericel Corp

    • Figure Revenue and Market Share Analysis of Vericel Corp

    • Table Product and Service Introduction of Vericel Corp

    • Table Company Profile and Development Status of Daiichi Sankyo Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Co Ltd

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo Co Ltd

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo Co Ltd

    • Table Product and Service Introduction of Daiichi Sankyo Co Ltd

    • Table Company Profile and Development Status of Holostem Terapie Avanzate Srl

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Holostem Terapie Avanzate Srl

    • Figure Sales and Growth Rate Analysis of Holostem Terapie Avanzate Srl

    • Figure Revenue and Market Share Analysis of Holostem Terapie Avanzate Srl

    • Table Product and Service Introduction of Holostem Terapie Avanzate Srl

    • Table Company Profile and Development Status of Brainstorm Cell Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Brainstorm Cell Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Brainstorm Cell Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Brainstorm Cell Therapeutics Inc

    • Table Product and Service Introduction of Brainstorm Cell Therapeutics Inc

    • Table Company Profile and Development Status of Sumitomo Chemical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Chemical Co Ltd

    • Figure Sales and Growth Rate Analysis of Sumitomo Chemical Co Ltd

    • Figure Revenue and Market Share Analysis of Sumitomo Chemical Co Ltd

    • Table Product and Service Introduction of Sumitomo Chemical Co Ltd

    • Table Company Profile and Development Status of FUJIFILM Holdings Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FUJIFILM Holdings Corp

    • Figure Sales and Growth Rate Analysis of FUJIFILM Holdings Corp

    • Figure Revenue and Market Share Analysis of FUJIFILM Holdings Corp

    • Table Product and Service Introduction of FUJIFILM Holdings Corp

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of Osiris Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Osiris Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Osiris Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Osiris Therapeutics Inc

    • Table Product and Service Introduction of Osiris Therapeutics Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.